NEO PRUNEX JAM 100 MG / 7 G
PHENOLPHTHALEIN : 100 MG / 7 G · DIN 00549533 · NEOLAB INC
Health Canada status: CANCELLED POST MARKET
What is NEO PRUNEX JAM?
NEO PRUNEX JAM 100 MG / 7 G contains PHENOLPHTHALEIN : 100 MG / 7 G. It is listed in the Health Canada Drug Product Database under DIN 00549533, held by NEOLAB INC, supplied as JAM for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 12-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00549533 |
|---|---|
| Brand name | NEO PRUNEX JAM |
| Generic / active ingredient | PHENOLPHTHALEIN : 100 MG / 7 G |
| Manufacturer | NEOLAB INC |
| Strength | 100 MG / 7 G |
| Dosage form | JAM |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AB04 PHENOLPHTHALEIN |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-Aug-1997 |
| Original market date | 1982-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AB04 PHENOLPHTHALEIN. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALOPHEN TAB 60MG | 60 MG | TABLET | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | DIN 01945955 |
| ESPOTABS LAXATIVE TABLETS 90MG | 90 MG | TABLET | COMBE INCORPORATED | CANCELLED POST MARKET | DIN 02052350 |
| EX-LAX CHOCOLATED TAB 95MG | 95 MG | TABLET | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 01907840 |
| FEEN-A-MINT PHENOLPHTHALEIN TAB 100MG | 100 MG | TABLET | SCHERING-PLOUGH HEALTHCARE PRODUCTS CANADA, A DIVISION OF SCHERING CANADA INC. | CANCELLED POST MARKET | DIN 01909932 |
| LAXATIVE PILLS - TABLET | 90 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 02176831 |
| LAXATIVE TABLETS | 94 MG | TABLET | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | DIN 02128047 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.